Log in
Enquire now
‌

US Patent 10286036 Protocol for treatment of lupus nephritis

Patent 10286036 was granted and assigned to Aurinia Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of lupus nephritis with voclosporin can be maximized while minimizing undesirable side effects.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10286036 Protocol for treatment of lupus nephritis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo